Autorenfreundlich Bücher kaufen?!
Beschreibung
This book provides detailed summary about Dipeptidyl Peptidase IV (DPP IV) Inhibitors in Management of Type 2 Diabetes. DPP IV inhibitors are established therapy for managing blood glucose in patients with type 2 diabetes. Several DPP IV inhibitors are developed in last few years and are used clinically all over the world. This book describes role of Glucagon Like Peptide-1 (GLP-1), an incretin hormone in insulin secretion and how DPP IV inhibitors affect action of GLP-1. It is followed by chemistry of DPP IV inhibitors and their lead optimization strategies for clinical development.
Details
| Verlag | LAP LAMBERT Academic Publishing |
| Ersterscheinung | 03. Oktober 2022 |
| Maße | 22 cm x 15 cm x 0.6 cm |
| Gewicht | 143 Gramm |
| Format | Softcover |
| ISBN-13 | 9786205508534 |
| Seiten | 84 |